Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

E.U. researchers patent viral compounds for synucleinopathies

March 10, 2021

AEON initiates phase II study of ABP-450 for preventive treatment of migraine

March 9, 2021

Xenon collaborates with Mount Sinai on phase II study of XEN-1101 for MDD and anhedonia

March 9, 2021

Clene Nanomedicine updates on clinical studies of CNM-Au8 gold nanocrystals

March 9, 2021

Injecting sRNAs from the putamen of HD patients reproduces associated neuropathology in mice

March 9, 2021

Macrophages dampen neuropathic pain

March 9, 2021

Roche patents mGlu4 receptor negative allosteric modulators

March 8, 2021

Melatonin repairs PNI through activation of the Shh signaling pathway in Schwann cells

March 8, 2021

Astrocytes are more inflammatory in bipolar disease

March 8, 2021

Neurons contribute to their own lack of regeneration

March 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...